Keryx Biopharmaceuticals 10K 2006 Annual report | KERX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: AA, Accumin, AccuminTM, ADI, adynamic, alopecia, aluminum, alveolar, anaplastic, anniversary, anticancer, AO, aortic, appeal, appealed, arbitration, astrocytoma, AusAm, Bankr, bankruptcy, binder, blinded, Bulletin, Ca, calcification, capecitabine, cationic, CFO, chain, Chapter, chondrosarcoma, chosen, cogent, cohort, concomitantly, convenient, conventional, coronary, correlated, counterclaim, customer, debatable, debtor, depression, diagnostic, dietary, discontinued, distinctly, Doxil, Duke, DVT, earth, economic, element, emphasizing, endometrial, escrow, exceed, exploit, exploratory, ferritin, flawed, forfeiture, Fowler, Friedman, GAAP, gastric, Global, goal, graph, hair, Hakko, Henry, hepatocellular, hydrogen, hyperparathyroidism, identification, ifosphamide, illustrating, immaterial, immune, indefinite, Index, inevaluable, instance, intact, ion, irinotecan, iron, killed, Kogyo, Kyowa, lanthanum, leadership, lenalidomide, liposomal, lived, liver, main, malignancy, margin, median, metastatic, MGMT, mild, mineralization, misinterpreted, mission, monotherapy, month, mTOR, multi, myxoid, network, newer, nonabsorbed, nonvested, oligodendroma, optimum, optionee, ordinary, osteodystrophy, overlooked, pAkt, pattern, PD, pemetrexed, persuasive, plausible, polymer, poor, predominantly, preliminarily, premium, proceeding, pronouncement, proper, quantified, quantifying, quantitative, radiation, rash, RCC, RDD, RECIST, reclassified, reconciliation, reinvestment, remission, residual, resolution, restricted, retention, Revlimid, rquire, run, SAB, SARC, saturation, Senator, settlement, Sevelamer, shareholder, shipped, skin, solid, sponsorship, staurosporine, step, stopped, suggest, suggested, SulonexTM, Taiwan, tangible, Task, thalidomide, Thirteen, threatening, thrombocytopenia, title, Tokyo, Topic, tract, traditionally, transferrin, unblinded, underwent, unrecognized, viable, vitamin, washout, women, Wyche, xenograft, ZerenexTM

Removed: accountant, AGT, beneficial, beneficially, collagen, comprised, continually, contractor, dermatan, dictate, dysfunction, engine, expression, fluctuated, gathering, hallmark, heparan, incorporate, influencing, inhibited, Jay, Kessel, Lawrence, leakage, Lindsay, lowered, mentioned, NIS, Peter, preliminary, prevented, preventive, progressing, proliferation, prototype, purpose, recruiting, recurring, reevaluated, regularly, removal, reorganization, repelling, replenished, researched, returning, reversed, rodent, Rosenwald, Salomon, shortened, studied, sulfate, thickening, today, unavailable, upstream, vacating

Keryx Biopharmaceuticals (KERX) 10-K2006 FY Annual report

Content analysis